These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 30607785

  • 41. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A, Meads D, Griffiths AW, Surr CA.
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [Abstract] [Full Text] [Related]

  • 42. Psychometric properties of the EQ-5D-5L in the general population of South Korea.
    Kim TH, Jo MW, Lee SI, Kim SH, Chung SM.
    Qual Life Res; 2013 Oct; 22(8):2245-53. PubMed ID: 23224560
    [Abstract] [Full Text] [Related]

  • 43. Validity, responsiveness and minimal important change of the EQ-5D-5L in patients after rotator cuff repair, shoulder arthroplasty or thumb carpometacarpal arthroplasty.
    Marks M, Grobet C, Audigé L.
    Qual Life Res; 2021 Oct; 30(10):2973-2982. PubMed ID: 33973108
    [Abstract] [Full Text] [Related]

  • 44. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.
    Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani LG.
    Qual Life Res; 2013 Sep; 22(7):1707-16. PubMed ID: 23192232
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
    Tsai APY, Hur SA, Wong A, Safavi M, Assayag D, Johannson KA, Morisset J, Fell C, Fisher JH, Manganas H, Shapera S, Cox G, Gershon AS, Hambly N, Khalil N, To T, Wilcox PG, Halayko A, Kolb MR, Ryerson CJ.
    Thorax; 2021 Jan; 76(1):37-43. PubMed ID: 33023996
    [Abstract] [Full Text] [Related]

  • 48. Validity of EQ-5D-5L in stroke.
    Golicki D, Niewada M, Buczek J, Karlińska A, Kobayashi A, Janssen MF, Pickard AS.
    Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
    [Abstract] [Full Text] [Related]

  • 49. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.
    Bató A, Brodszky V, Gergely LH, Gáspár K, Wikonkál N, Kinyó Á, Szabó Á, Beretzky Z, Szegedi A, Remenyik É, Kiss N, Sárdy M, Rencz F.
    Qual Life Res; 2021 May; 30(5):1477-1490. PubMed ID: 33534032
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.
    Zhou W, Shen A, Yang Z, Wang P, Wu B, Herdman M, Busschbach J, Luo N.
    Eur J Health Econ; 2024 Nov; 25(8):1361-1370. PubMed ID: 38356007
    [Abstract] [Full Text] [Related]

  • 53. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.
    Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J.
    Qual Life Res; 2013 Sep; 22(7):1717-27. PubMed ID: 23184421
    [Abstract] [Full Text] [Related]

  • 54. A Direct Comparison of the Measurement Properties of EQ-5D-5L, PROMIS-29+2 and PROMIS Global Health Instruments and EQ-5D-5L and PROPr Utilities in a General Population Sample.
    Rencz F, Brodszky V, Janssen MF.
    Value Health; 2023 Jul; 26(7):1045-1056. PubMed ID: 36804583
    [Abstract] [Full Text] [Related]

  • 55. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y, Devlin N, Herdman M.
    Health Qual Life Outcomes; 2015 Oct 21; 13():171. PubMed ID: 26489956
    [Abstract] [Full Text] [Related]

  • 56. Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry.
    Latteur J, Ernstsson O, Nilsson E, Jäghult S, Heintz E.
    J Patient Rep Outcomes; 2024 Mar 27; 8(1):39. PubMed ID: 38536626
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
    Xin Y, McIntosh E.
    Qual Life Res; 2017 Jan 27; 26(1):1-23. PubMed ID: 27778141
    [Abstract] [Full Text] [Related]

  • 59. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
    Xu RH, Zhu L, Sun R, Tan RL, Luo N, Zou S, Dong D.
    Eur J Pediatr; 2022 Dec 27; 181(12):4049-4058. PubMed ID: 36156120
    [Abstract] [Full Text] [Related]

  • 60. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
    Easton T, Milte R, Crotty M, Ratcliffe J.
    Qual Life Res; 2018 May 27; 27(5):1283-1294. PubMed ID: 29305782
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.